A Chlamydomonas-derived Human Papillomavirus 16 E7 vaccine induces specific tumor protection.

<h4>Background</h4>The E7 protein of the Human Papillomavirus (HPV) type 16, being involved in malignant cellular transformation, represents a key antigen for developing therapeutic vaccines against HPV-related lesions and cancers. Recombinant production of this vaccine antigen in an act...

Full description

Saved in:
Bibliographic Details
Main Authors: Olivia C Demurtas, Silvia Massa, Paola Ferrante, Aldo Venuti, Rosella Franconi, Giovanni Giuliano
Format: article
Language:EN
Published: Public Library of Science (PLoS) 2013
Subjects:
R
Q
Online Access:https://doaj.org/article/0963fa34853949e3bb62bab97b1d3536
Tags: Add Tag
No Tags, Be the first to tag this record!